| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/24/1994 | EP0564587A4 Solution phase process for synthesis of peptide |
| 08/24/1994 | EP0556344A4 New insulin-like growth factor binding protein (igfbp-6) |
| 08/24/1994 | EP0533701B1 SHUTTLE VECTOR FOR RECOMBINANT $i(BACILLUS THURINGIENSIS) STRAIN DEVELOPMENT |
| 08/24/1994 | EP0504191B1 Method and composition for the treatment of mammalian hiv infection |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0461165B1 Yeast processing system comprising a negatively charged amino acid adjacent to the processing site |
| 08/24/1994 | EP0359745B1 Growth factor receptor |
| 08/24/1994 | EP0358708B1 Blood substitutes |
| 08/24/1994 | EP0270611B1 TRANSLATION OF mRNA |
| 08/24/1994 | CN1091138A Vaccines |
| 08/23/1994 | WO1994019371A1 Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/23/1994 | USRE34705 Nucleotidic sequence coding the surface antigen of the hepatitis B virus, vector containing said nucleotidic sequence, process allowing the obtention thereof and antigen obtained thereby |
| 08/23/1994 | US5340935 DNAS encoding proteins active in lymphocyte-medicated cytotoxicity |
| 08/23/1994 | US5340934 CDNA sequences of human bone matrix proteins |
| 08/23/1994 | US5340925 A heptapeptides as receptor of transforming growth factor-beta |
| 08/23/1994 | US5340924 Adjusting pH to acidic range before heating |
| 08/23/1994 | US5340922 Polypeptide |
| 08/23/1994 | US5340921 Γ, δT cell receptor and methods and detection |
| 08/23/1994 | US5340920 Physiologically active porcine peptide (CNP-53) |
| 08/23/1994 | US5340800 Peptide medicaments for the treatment of disease |
| 08/23/1994 | US5340750 Reagents and methods for the quantification of imipramine or desipramine in biological fluids |
| 08/23/1994 | US5340739 Hematopoietic cell specific transcriptional regulatory elements of serglycin and uses thereof |
| 08/23/1994 | US5340736 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 08/23/1994 | US5340732 Antiviral protein |
| 08/23/1994 | US5340731 Method of preparing a B-1,4 glycan matrix containing a bound fusion protein |
| 08/23/1994 | US5340727 GPIbα fragments and recombinant DNA expression vectors |
| 08/23/1994 | US5340726 Protein for inhibiting collagen-stimulated platelet aggregation |
| 08/23/1994 | US5340725 Expression vector for insulin-like growth factor I and method of production |
| 08/23/1994 | US5340718 Method for assaying a human muscular dystrophy protein |
| 08/23/1994 | US5340575 Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen |
| 08/23/1994 | US5340574 Stabilized non-glycosylated recombinant human IL2 in reduced form compositions |
| 08/23/1994 | CA2115972A1 Cyclopeptide derivatives of angiopeptin, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/23/1994 | CA2115900A1 Pharmaceutical screens and antibodies |
| 08/23/1994 | CA1331615C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| 08/23/1994 | CA1331614C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline- 3-carboxylic acids |
| 08/23/1994 | CA1331571C Process for the chemical modification of protides and products modified by said process |
| 08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
| 08/20/1994 | CA2115913A1 Alcohol or aldehyde derivatives and their use |
| 08/18/1994 | WO1994018571A1 Mcf-7 binding site assays |
| 08/18/1994 | WO1994018563A1 Detection of type ii collagen and its peptides |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994018560A1 Method of assaying human tau protein, kit therefor, and diagnostic method |
| 08/18/1994 | WO1994018346A1 Cholesterol 7-alpha hydroxylase expression regulation |
| 08/18/1994 | WO1994018341A1 Apparatus and process for continuous $i(in vitro) synthesis of peptides |
| 08/18/1994 | WO1994018335A2 Method of controlling plant pathogenic fungi |
| 08/18/1994 | WO1994018332A2 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | WO1994018330A1 Immobilized proteins with specific binding capacities and their use in processes and products |
| 08/18/1994 | WO1994018329A2 Serine protease variants having peptide ligase activity |
| 08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | WO1994018326A2 Regulatory gene for clavulanic acid biosynthesis |
| 08/18/1994 | WO1994018325A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 08/18/1994 | WO1994018321A1 GLYCAM-1 (SgP50) VARIANTS |
| 08/18/1994 | WO1994018319A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof |
| 08/18/1994 | WO1994018318A1 Totally synthetic affinity reagents |
| 08/18/1994 | WO1994018317A1 Regulated transcription of targeted genes and other biological events |
| 08/18/1994 | WO1994018316A2 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS |
| 08/18/1994 | WO1994018313A1 Functional domains in flavobacterium okeanokoites (foki) restriction endonuclease |
| 08/18/1994 | WO1994018309A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | WO1994018240A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof |
| 08/18/1994 | WO1994018239A1 Control of cell proliferation |
| 08/18/1994 | WO1994018238A1 Preparation of nucleic acids using acid protease |
| 08/18/1994 | WO1994018237A1 Novel peptide having receptor activity and dna coding for said peptide |
| 08/18/1994 | WO1994018236A1 Receptor-binding determinant from leukaemia inhibitory factor |
| 08/18/1994 | WO1994018234A1 Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains |
| 08/18/1994 | WO1994018233A1 Thymosin alpha-1 derivatives |
| 08/18/1994 | WO1994018232A1 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| 08/18/1994 | WO1994018228A1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof |
| 08/18/1994 | WO1994018227A2 Improved method for the refolding of proteins |
| 08/18/1994 | WO1994018223A1 Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients |
| 08/18/1994 | WO1994018222A1 Nuclear matrix proteins |
| 08/18/1994 | WO1994018217A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
| 08/18/1994 | WO1994017834A1 Method for inactivating viruses devoid of lipid envelopes |
| 08/18/1994 | WO1994017832A1 Targeting and delivery of genes and antiviral agents into cells by the adenovirus penton |
| 08/18/1994 | WO1994017828A2 Treatment for insulin dependent diabetes |
| 08/18/1994 | WO1994017826A1 Vaccinal polypeptides |
| 08/18/1994 | WO1994017825A1 Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use |
| 08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
| 08/18/1994 | WO1994017816A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | WO1994017813A1 Defective sindbis virus vectors that express toxoplasma gondii p30 antigens |
| 08/18/1994 | WO1994017810A1 Recombinant cytomegalovirus vaccine |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994014960A3 Protocadherin, their autibodies and uses |
| 08/18/1994 | WO1994014957A3 Dna encoding 5-ht4 serotonin receptors and uses thereof |
| 08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
| 08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
| 08/18/1994 | WO1993008259A3 Inhibitors of dipeptidyl-aminopeptidase type IV |
| 08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1994 | DE4304731A1 Thrombin inhibitor from the saliva of protostomes |
| 08/18/1994 | CA2155725A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | CA2155661A1 Detection of type ii collagen and its peptides |
| 08/18/1994 | CA2155646A1 Phospho-specific antibodies against a creb derived peptide |
| 08/18/1994 | CA2155645A1 Nuclear matrix proteins |
| 08/18/1994 | CA2155554A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | CA2155514A1 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |